Agreed. Also what was stated in the emails at the start of this thread I assumed was common knowledge, especially if you read the announcement carefully I don't believe they would be happy to lose 250k if they had no intention to pursue BCC further
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%